These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1578361

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS, Derkx FH, Boomsma F, Brommer EJ, Schalekamp MA.
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [Abstract] [Full Text] [Related]

  • 3. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG, Razi M, Lonergan M, Arthus MF, Papukna V, Kortas C, Barjon JN.
    N Engl J Med; 1988 Apr 07; 318(14):881-7. PubMed ID: 2965301
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.
    Kaufmann JE, Oksche A, Wollheim CB, Günther G, Rosenthal W, Vischer UM.
    J Clin Invest; 2000 Jul 07; 106(1):107-16. PubMed ID: 10880054
    [Abstract] [Full Text] [Related]

  • 8. Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility.
    Lethagen S, Harris AS, Sjörin E, Nilsson IM.
    Thromb Haemost; 1987 Dec 18; 58(4):1033-6. PubMed ID: 3127915
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Subcutaneous injection of desmopressin (DDAVP) for increasing factor VIII and von Willebrand factor in plasmapheresis].
    Köhler M, Kotitschke R, Braun B, Hellstern P, Mörsdorf S, Pindur G, Heiden M, Wenzel E.
    Beitr Infusionsther; 1990 Dec 18; 26():136-41. PubMed ID: 1703813
    [Abstract] [Full Text] [Related]

  • 11. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH, Man in 't Veld AJ, Jones R, Reid JL, Schalekamp MA.
    J Hypertens Suppl; 1983 Dec 18; 1(2):58-61. PubMed ID: 6400119
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
    Casonato A, Dannhauser D, Pontara E, Bertomoro A, Orazi B, Santarossa L, Zerbinati P, Girolami A.
    Blood Coagul Fibrinolysis; 1996 Jul 18; 7(5):549-53. PubMed ID: 8874865
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. L-NAME antagonizes vasopressin V2-induced vasodilatation in dogs.
    Liard JF.
    Am J Physiol; 1994 Jan 18; 266(1 Pt 2):H99-106. PubMed ID: 8304528
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.